Theruptor novo: wound dressing for diabetic foot ulcer
DOI:
https://doi.org/10.18203/2349-2902.isj20233535Keywords:
Diabetes mellitus, Diabetic foot ulcer, Wound dressings, Theruptor Novo dressingAbstract
One of the main risk factor affecting the normal wound healing process of is diabetes. India being the capital for diabetes, has a prevalence of 9.6% with 74 million patients living with diabetes and is expected to be 124 million by 2045. The most dreadful complication of diabetes mellitus is the diabetic foot ulcer. Foot ulcer and amputation are among the leading reasons for high morbidity, healthcare costs and mortality in diabetes patients. Numerous things must come together for a chronic wound to heal, and one crucial component of care is the use of wound dressings and these should create an ideal environment for healing while safeguarding the site from infection and additional damage. A diabetic patient presented with a non-healing diabetic foot ulcer (10.83 cm2) with severe loss of protective sensation, exposed excised fourth and fifth metatarsals and he was treated and followed up with regular normal saline washes and Theruptor Novo dressings. The wound started to show signs of healing and within 7 weeks, the wound healed with complete epithelization. Theruptor Novo dressing was helpful in terms of good granulation tissue growth and epithelialization over time with good exudate management. Theruptor Novo, a non-adherent dressing with unique antimicrobial action cab be useful in managing diabetic foot ulcers.
References
Dhivya S, Padma VV, Santhini E. Wound dressings - a review. Biomedicine (Taipei). 2015;5(4):22.
International Diabetes Federation. Diabetes Atlas (2006) Available at: https://diabetesatlas.org/idfawp/ resource files/2021/07/IDF_Atlas_10th_Edition_ 2021.pdf. Accessed on 26 October 2023.
Subhash C. Diabetic foot ulcer–a case study. J Exercise Sci Physiotherap. 2005;1:98-9.
Alkhatieb M, Mortada H, Aljaaly H. Management of a Difficult-to-Treat Diabetic Foot Wound Complicated by Osteomyelitis: A Case Study. Case Rep Surg. 2020;3971581.
Mandewo W, Edodge E, Chideme-Munodawafa A, Mandewo G. Non-adherence to treatment among diabetic patients attending outpatient clinic at Mutare provincial hospital, Manicaland province, Zimbabwe. Int J Scientific Technol Res. 2014;3:66-86.
Boyko EF, Forsberg RC, Davignon DR, Smith DG, Ahroni JH, Stensel V. A Prospective Study of Risk Factors for Diabetic Foot Ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036-42.
Britto EJ, Nezwek TA, Popowicz P. Wound Dressings. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023.
Gupta R, Murthy KVNNS, Bhagavan KR, Moharana AK, Rodrigues M, Deepak TS. Antimicrobial properties of Theruptor 3D-hydrocellular wound dressing: An in vitro study. Int J Surg Open. 2022;46:100528.
Kavitha KV, Tiwari S, Purandare VB, Khedkar S, Bhosale SS, Unnikrishnan AG. Choice of wound care in diabetic foot ulcer: A practical approach. World J Diabetes. 2014;5(4):546-56.
Sood A, Granick MS, Tomaselli NL. Wound Dressings and Comparative Effectiveness Data. Adv Wound Care (New Rochelle). 2014;3(8):511-29.
Ray R, Sarkar R, Gupta S, Halder T, Trushield NXT. Non Adherent Wound Dressing versus Standard of Care Dressing among Women Undergoing Obstetric and Gynaecological Surgeries: A Randomised Clinical Study. J Clin Diagn Res. 2022;16(12):QC27-32.
Tong JW. Case reports on the use of antimicrobial (silver impregnated) soft silicone foam dressing on infected diabetic foot ulcers. Int Wound J. 2009;6(4):275-84.
